Any stock, in context
KILITCH · Healthcare
Kilitch Drugs (India) Limited
Observation · 15 Oct 2026
How these are readKilitch Drugs (India) closed at ₹236.2 on 15 Oct 2026, 35.1% above its 200-day average and 20.1% above its 50-day average: above both lines. It sits 9.4% below its highest close of the past year, in the fourth fifth of its one-year range. Over three months it rose 29.6%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- Thinly traded: under ₹1 crore a day
- vs 200-day
- +35.1%
- the long line
- vs 50-day
- +20.1%
- the short line
- From 52w high
- −9.4%
- ₹117.3₹267.9
- 3 months
- +29.6%
- sector median −2.7% · 13 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · EQ series · median traded value ₹0.50 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- +2.53%
- 1W
- –
- 1M
- +24.19%
- 3M
- +29.65%
- YTD
- –
- 1Y
- +32.98%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.